Total Payments
$7,868
2024 Payments
$1,292
Companies
37
Transactions
391
Medicare Patients
17,634
Medicare Billing
$1.0M
Payment Breakdown by Category
Food & Beverage$7,664 (97.4%)
Education$203.58 (2.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,664 | 386 | 97.4% |
| Education | $203.58 | 5 | 2.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,180 | 79 | $0 (2024) |
| DUSA Pharmaceuticals, Inc. | $934.11 | 3 | $0 (2017) |
| Janssen Biotech, Inc. | $889.86 | 40 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $744.53 | 41 | $0 (2024) |
| Lilly USA, LLC | $524.61 | 29 | $0 (2024) |
| UCB, Inc. | $418.92 | 19 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $408.05 | 18 | $0 (2024) |
| Genentech USA, Inc. | $347.04 | 15 | $0 (2020) |
| Regeneron Healthcare Solutions, Inc. | $341.52 | 18 | $0 (2024) |
| Mayne Pharma Inc. | $292.45 | 25 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,292 | 68 | Janssen Biotech, Inc. ($244.72) |
| 2023 | $917.99 | 41 | Janssen Biotech, Inc. ($199.48) |
| 2022 | $249.40 | 14 | Lilly USA, LLC ($50.23) |
| 2021 | $676.31 | 41 | AbbVie Inc. ($185.35) |
| 2020 | $448.96 | 21 | Genentech USA, Inc. ($97.82) |
| 2019 | $1,255 | 77 | AbbVie, Inc. ($282.14) |
| 2018 | $979.15 | 62 | Janssen Biotech, Inc. ($138.78) |
| 2017 | $2,049 | 67 | DUSA Pharmaceuticals, Inc. ($934.11) |
All Payment Transactions
391 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $33.06 | General |
| Category: Immunology | ||||||
| 12/11/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $26.21 | General |
| Category: Dermatology | ||||||
| 12/04/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: Immunology | ||||||
| 11/21/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $28.58 | General |
| Category: Immunology | ||||||
| 11/12/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: Immunology | ||||||
| 11/07/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: Inflammation | ||||||
| 11/07/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $4.13 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $36.52 | General |
| Category: Immunology | ||||||
| 10/24/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $26.96 | General |
| Category: Dermatology | ||||||
| 10/20/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $31.34 | General |
| Category: Immunology | ||||||
| 10/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $1.79 | General |
| Category: IMMUNOLOGY | ||||||
| 10/17/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $6.81 | General |
| Category: IMMUNOLOGY | ||||||
| 10/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $1.93 | General |
| Category: IMMUNOLOGY | ||||||
| 10/15/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $23.65 | General |
| Category: Dermatology | ||||||
| 10/07/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: Immunology | ||||||
| 10/05/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.89 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/01/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $22.92 | General |
| Category: IMMUNOLOGY | ||||||
| 09/26/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: IMMUNOLOGY | ||||||
| 09/24/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $28.74 | General |
| Category: Immunology | ||||||
| 09/10/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: Inflammation | ||||||
| 08/23/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: Immunology | ||||||
| 08/21/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $27.71 | General |
| Category: IMMUNOLOGY | ||||||
| 08/16/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: IMMUNOLOGY | ||||||
| 08/14/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $42.74 | General |
| Category: Immunology | ||||||
| 08/13/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $6.55 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 3,923 | 6,916 | $733,098 | $232,534 |
| 2022 | 21 | 4,365 | 7,656 | $821,697 | $248,954 |
| 2021 | 19 | 4,661 | 8,245 | $819,748 | $272,602 |
| 2020 | 25 | 4,685 | 8,207 | $725,235 | $250,078 |
Total Patients
17,634
Total Services
31,024
Medicare Billing
$1.0M
Procedure Codes
81
All Medicare Procedures & Services
81 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 1,503 | 1,821 | $306,370 | $95,737 | 31.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 423 | 478 | $97,757 | $32,043 | 32.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 644 | 774 | $94,867 | $26,303 | 27.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 262 | 294 | $53,900 | $16,897 | 31.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 507 | 2,880 | $34,474 | $12,672 | 36.8% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 85 | 111 | $34,081 | $12,282 | 36.0% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 65 | 77 | $20,749 | $6,403 | 30.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 95 | 95 | $19,866 | $5,856 | 29.5% |
| 17271 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm | Office | 2023 | 44 | 49 | $14,957 | $5,314 | 35.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 139 | 147 | $15,329 | $5,096 | 33.2% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 32 | 38 | $12,409 | $4,492 | 36.2% |
| 17281 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 26 | 32 | $10,557 | $3,395 | 32.2% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 46 | 62 | $5,664 | $2,161 | 38.1% |
| 69100 | Biopsy of ear | Office | 2023 | 28 | 31 | $5,457 | $1,462 | 26.8% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 13 | 16 | $3,848 | $1,447 | 37.6% |
| 17280 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less | Office | 2023 | 11 | 11 | $2,813 | $974.70 | 34.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 1,524 | 1,852 | $314,840 | $95,420 | 30.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 480 | 534 | $109,876 | $34,826 | 31.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 723 | 854 | $105,452 | $27,270 | 25.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 287 | 318 | $59,307 | $16,650 | 28.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 546 | 3,201 | $39,052 | $14,114 | 36.1% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 89 | 110 | $33,955 | $11,408 | 33.6% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2022 | 89 | 108 | $29,225 | $8,785 | 30.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 180 | 192 | $20,148 | $6,493 | 32.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 107 | 107 | $22,483 | $5,772 | 25.7% |
About Dr. Jenifer Insley, MD
Dr. Jenifer Insley, MD is a Dermatology healthcare provider based in Springfield, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1801866231.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jenifer Insley, MD has received a total of $7,868 in payments from pharmaceutical and medical device companies, with $1,292 received in 2024. These payments were reported across 391 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($7,664).
As a Medicare-enrolled provider, Insley has provided services to 17,634 Medicare beneficiaries, totaling 31,024 services with total Medicare billing of $1.0M. Data is available for 4 years (2020–2023), covering 81 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Other Specialties Military Health Care Provider
- Location Springfield, MO
- Active Since 01/26/2006
- Last Updated 08/02/2016
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1801866231
Products in Payments
- Levulan (Drug) $551.38
- TREMFYA (Drug) $512.74
- TALTZ (Drug) $453.07
- Humira (Biological) $404.65
- Odomzo (Drug) $382.73
- Erivedge (Biological) $347.04
- DUPIXENT (Biological) $299.33
- STELARA (Biological) $294.44
- Otezla (Drug) $293.54
- DORYX (Drug) $292.45
- ILUMYA (Biological) $275.73
- SKYRIZI (Biological) $265.28
- COSENTYX (Drug) $256.78
- RINVOQ (Biological) $243.69
- COSENTYX (Biological) $242.25
- Cimzia (Drug) $214.27
- Bimzelx (Biological) $204.65
- Sotyktu (Drug) $189.15
- ENSTILAR (Drug) $167.97
- EUCRISA (Drug) $160.61
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Springfield
Dr. Shannon Trotter, D.o, D.O
Dermatology — Payments: $261,835
Dermatology $261,835
Dr. Peter Demos, M.d, M.D
Dermatology — Payments: $19,423
Dermatology $19,423
Dr. Joshua Dimmick, Md, MD
Dermatology — Payments: $14,304
Dermatology $14,304
Dr. Vivianne Beyer, M.d, M.D
Dermatology — Payments: $13,294
Dermatology $13,294
Catherine Laughlin, Md, MD
Dermatology — Payments: $6,097
Dermatology $6,097
Mr. Robert Deangelis, Md, MD
Dermatology — Payments: $5,096
Dermatology $5,096